Today, a federal scientist announced that diabetes drug Avandia should be pulled from the market. Avandia drug maker Glaxo Smith Kline of course disputes these recommendations.
The expert maintains that Avandia should be pulled from the market because of heart risks associated with consuming the drug and the drug’s lack of any unique short-term benefits in maintaining blood-sugar levels for diabetics.
The FDA is currently meeting to determine whether Avandia should be restricted or completely pulled from the market. The FDA was alerted to the dangers of Avandia by a New England Journal of Medicine study that showed a 43% higher risk of heart attack by those taking Avandia compared with patients taking alternative diabetes medication.
Patients who have endured heart attacks or heart problems and who have taken Avandia may be entitled to compensation for these injuries.
Click here for the full article